Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
Giant cell arteritis (GCA) can be a devastating disease resulting in blindness if not promptly diagnosed and treated. The only proven treatment for GCA is systemic corticosteroids; however, there are many side-effects associated with this therapy including ocular side-effects such as ocular hypertension, cataract formation and central serous chorioretinopathy. To raise physician awareness, a patient with biopsy-proven GCA is reported who lost vision during corticosteroid therapy because of central serous chorioretinopathy.
Bevis
Timothy
T
Department of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida, USA.
Ratnakaram
Ramakrishna
R
Smith
M Fran
MF
Bhatti
M Tariq
MT
D001766:Blindness / Q000209:etiology*; D001769:Blood; D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D005451:Fluorescein Angiography; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008775:Methylprednisolone; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D014792:Visual Acuity
D005938:Glucocorticoids; D011239:Prednisolone; D008775:Methylprednisolone